MICROBPLEX
MicroBPlex is developing a diagnostic platform to identify microbial infections, particularly pneumonia and influenza. The diagnostic uses a matrix of newly synthesized antibodies that are secreted by specialized Antibody Secreting Cells (ASCs) that circulate in a patient’s blood during acute infections.
MICROBPLEX
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2011-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Status:
Active
Total Funding:
248.68 K USD
Current Employees Featured
Founder
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - MicroBplex
Georgia Research Alliance
Georgia Research Alliance investment in Grant - MicroBplex
Georgia Research Alliance
Georgia Research Alliance investment in Grant - MicroBplex
Georgia Research Alliance
Georgia Research Alliance investment in Grant - MicroBplex
More informations about "MicroBplex"
Company | MicroBplex | Diagnostic Certainty
MicroBplex, Inc. is an in vitro diagnostics biotechnology company based in Atlanta, GA. We formed MicroBplex to develop and commercialize a novel patent – pending diagnostic …See details»
MicroBplex - Crunchbase Company Profile & Funding
MicroBPlex is developing a diagnostic platform to identify microbial infections, particularly pneumonia and influenza. The diagnostic uses a matrix of newly synthesized antibodies that …See details»
MicroBplex Company Profile 2024: Valuation, Funding …
Operator of a biotechnology company intended to develop novel technology to detect nascent antibody-secreting cells (ASCs).See details»
MicroBplex Company Profile | Management and Employees List
Find contact information for MicroBplex. Learn about their Medical Devices & Equipment, Manufacturing market share, competitors, and MicroBplex's email format.See details»
MicroBplex, Inc. Company Profile | Atlanta, GA | Competitors ...
Find company research, competitor information, contact details & financial data for MicroBplex, Inc. of Atlanta, GA. Get the latest business insights from Dun & Bradstreet.See details»
MicroBplex - Funding, Financials, Valuation & Investors - Crunchbase
MicroBPlex is developing a diagnostic platform to identify microbial infections.See details»
Technology | MicroBplex | Diagnostic Certainty
MicroBplex’s approach to diagnostics for infectious diseases is to detect the presence in blood of ASCs that synthesize antibodies that bind the pathogen thought to be responsible for the infection.See details»
MicroBplex - Crunchbase
MicroBPlex is developing a diagnostic platform to identify microbial infections.See details»
Georgia Research Alliance - GRA
MicroBPlex is developing a diagnostic platform to identify microbial infections, particularly pneumonia and influenza. The diagnostic uses a matrix of newly synthesized antibodies that …See details»
Founders | MicroBplex | Diagnostic Certainty
Her clinical focus is in providing comprehensive care to adult patients with severe asthma in the Atlanta area. As a pulmonary immunologist, her research focus is in understanding the biology …See details»
Frances Eun-Hyung Lee - Co-Founder @ MicroBplex - Crunchbase
Frances Eun-Hyung Lee is the Co-Founder at MicroBplex. Additionally, Frances Eun-Hyung Lee has had 1 past job as the Assistant Professor at Emory University School of Medicine.See details»
Products | MicroBplex | Diagnostic Certainty
MicroBplex’ technology overcomes these limitations of other diagnostic approaches by enabling detection of the patient’s earliest cellular immune response to infectious pathogens without the …See details»
MicroBplex - Contacts, Employees, Board Members, Advisors
MicroBPlex is developing a diagnostic platform to identify microbial infections.See details»
Lyme Disease | MicroBplex | Diagnostic Certainty
We measure the newly synthesized ASC antibodies with a sensitive multiplexed Luminex™ immunoassay platform.See details»
MicroBplex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
MicroBPlex is developing a diagnostic platform to identify microbial infections.See details»
John L. Daiss - Co-Founder @ MicroBplex - Crunchbase
John L. Daiss is the Co-Founder of MicroBplex. He previously worked at First Wave Technologies. John L. Daiss attended Johns Hopkins University and Massachusetts Institute …See details»
Clostridium Difficile | MicroBplex | Diagnostic Certainty
HOW MICROBPLEX IS HELPING. MENSA is a defined cell culture medium containing the newly synthesized antibodies secreted by ASCs harvested from the blood of subjects suspected to …See details»